| 2017-2018 SALES RANK | 12 |
| 2017-18 SALES (IN BILLIONS $ U.S.) | 19.71* |
| FISCAL YEAR-END | Dec. |
| SYSTEMWIDE STORES FISCAL 2017-18 | 9730 |
| BRANDS/CONCEPTS | CVS Pharmacy; CVS; Longs Drugs; Navarro Discount Pharmacy |
| HEADQUARTERS | Woonsocket R.I. |
| STORE FORMAT | Drug chain |
| KEY EXECUTIVES | Larry J. Merlo / president and CEO |
| NOTES | Estimated consumables sales for fiscal 2017 ended in December represent the non-prescription-drug share or 25% of estimated total U.S. retail pharmacy and long-term care (LTC) business sales of $78.82 billion. The non-prescription-drug share was 25% of reported division sales in fiscal 2016 when estimated U.S. pharmacy and long-term care sales reached $80.81 billion. Store count and sales shown exclude retail pharmacies in Brazil with an estimated 38 operating at year-end fiscal 2017 when they generated an estimated 0.4% of divisional sales. Total estimated fiscal 2017 net sales from pharmacy services as well as retail-LTC affairs were $183.96 billion compared with FY16's $177.53 billion. |
